SPR1

N/A

Report date: 2022/12/19 14:47:29
NME

Base Information

Drug NameSPR1
Drug Alias NameSPR-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor inhibitorsTafazzin inhibitors
TargetsTranscriptional enhancer factorTafazzin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSporos BioDiscovery Inc
China Registration ClassN/A

Develop Information

Active CompaniesSporos BioDiscovery Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A